Context: Sepsis is a serious health problem in the elderly with a high degree of mortality. There is very limited data available in elderly subjects regarding the markers for sepsis. Development of good markers will help in overall management and prediction of sepsis. Objectives: Serial estimation of Interleukin-6 (IL-6) and Tumor Necrosis Factor-Alpha (TNF-α) and their correlation with mortality in sepsis in elderly patients and to determine the influence of gender on cytokine production and mortality in elderly patients with sepsis. Settings and Design: The prospective study was conducted at our tertiary care center from April 2007 to September 2008. Elderly Patients satisfying the Systemic Inflammatory Response Syndrome (SIRS) criteria were included. Methods and Material: TNF-α and IL-6 were estimated in 30 elderly patients admitted to our intensive care unit with SIRS and sepsis. The estimations were done on day 1, 3 and 7 of admission. Statistical Analysis Used: Student and paired ′t′ tests, and ANOVA, which were further followed up by post-hoc ′t′ tests with Bonferroni correction using SPSS. Results: Reducing levels of IL-6 levels from day 1 to 7 was found in the survivor group. TNF-α level was significantly low on day 1 in the nonsurvivor female group. Conclusions: Serial estimation of cytokines in elderly patients with sepsis will help in prediction of mortality. Female gender was an independent predictor of increased morality in critically ill patients with sepsis.
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006;34:15-21.
The “cytokine profile”: a code for sepsis. Trends Mol Med 2005;1156-63.
Epidemiology of severe sepsis in India. Crit Care 2007;11:65.
Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 2002;34:1084-93.
Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003;31:1560-7.
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med 1993;21:318-27.
Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000;180:176-80.
Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997;156:825-32.
Clinical significance of inflammation markers in abdominal sepsis patients. Vestn Khir Im I I Grek 2007;166:40-3.
Cytokine-release patterns in elderly patients with systemic inflammatory response syndrome. Gerontology 2007;53:239-44.
Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005;23:488-93.
Cytokine profiles as markers of disease severity in sepsis; a multiplex analysis. Crit Care 2007;11:49.
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007;167:1655-63.
Gender-based differences in outcome in patients with sepsis. Arch Surg 1999;134:1342-7.
Gender differences in human sepsis. Arch Surg 1998;133:1200-5.
Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 2007;132:1786-93.
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10.
The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med 2006;34:2576-82.
Gender dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA 1999;282:2143-8.
Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000;26:167-72.
Gender-related differences in intensive care: a multiple-center cohort study of therapeutic interventions and outcoe in critically ill patients. Crit Care Med 2003;31:1901-7.
Sepsis and sex: can we look beyond our hormones? Chest 2007;132:1725-7.
Women and access to health care. Soc Sci Med 1992;35:619-26.
Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990;87:1233-7.
Sexual dimorphism in innate immunity. Arthritis Rheum 2002;46:250-8.
The influence of gender on human innate immunity. Surgery 2005;138:275-82.